These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17244850)

  • 1. Exhaustion is associated with low macrophage migration inhibitory factor expression in patients with coronary artery disease.
    Kwaijtaal M; van der Ven AJ; van Diest R; Bruggeman CA; Bär FW; Calandra T; Appels A; Sweep FC
    Psychosom Med; 2007 Jan; 69(1):68-73. PubMed ID: 17244850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of treating exhaustion in angioplasty patients on new coronary events: results of the randomized Exhaustion Intervention Trial (EXIT).
    Appels A; Bär F; van der Pol G; Erdman R; Assman M; Trijsburg W; van Diest R; van Dixhoorn J; Mendes de Leon C
    Psychosom Med; 2005; 67(2):217-23. PubMed ID: 15784786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.
    Emonts M; Sweep FC; Grebenchtchikov N; Geurts-Moespot A; Knaup M; Chanson AL; Erard V; Renner P; Hermans PW; Hazelzet JA; Calandra T
    Clin Infect Dis; 2007 May; 44(10):1321-8. PubMed ID: 17443469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, macrophage migration inhibitory factor, and weight loss.
    Church TS; Willis MS; Priest EL; Lamonte MJ; Earnest CP; Wilkinson WJ; Wilson DA; Giroir BP
    Int J Obes (Lond); 2005 Jun; 29(6):675-81. PubMed ID: 15795748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory markers predict late cardiac events in patients who are exhausted after percutaneous coronary intervention.
    Kwaijtaal M; van Diest R; Bär FW; van der Ven AJ; Bruggeman CA; de Baets MH; Appels A
    Atherosclerosis; 2005 Oct; 182(2):341-8. PubMed ID: 16159607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis.
    Ren Y; Lin CL; Li Z; Chen XY; Huang X; Lui V; Nicholls J; Lan HY; Tam PK
    Histopathology; 2005 Jun; 46(6):659-67. PubMed ID: 15910597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
    Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
    Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most of the interleukin 1 receptor antagonist, cathepsin S, macrophage migration inhibitory factor, nerve growth factor, and interleukin 18 release by explants of human adipose tissue is by the non-fat cells, not by the adipocytes.
    Fain JN; Tichansky DS; Madan AK
    Metabolism; 2006 Aug; 55(8):1113-21. PubMed ID: 16839849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease.
    Janszky I; Lekander M; Blom M; Georgiades A; Ahnve S
    Brain Behav Immun; 2005 Nov; 19(6):555-63. PubMed ID: 16214026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
    Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
    Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
    Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
    Makino A; Nakamura T; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Watanabe K; Watanabe Y; Kawabata K; Obata JE; Kugiyama K
    Atherosclerosis; 2010 Dec; 213(2):573-8. PubMed ID: 20934703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
    Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
    Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
    Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
    J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-D personality exerts a stable, adverse effect on vital exhaustion in PCI patients treated with paclitaxel-eluting stents.
    Pedersen SS; Daemen J; van de Sande M; Sonnenschein K; Serruys PW; Erdman RA; van Domburg RT
    J Psychosom Res; 2007 Apr; 62(4):447-53. PubMed ID: 17383496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between expression of macrophage migration inhibitory factor and prognosis of breast cancer].
    Xu XD; Yao C; Lin Y; Wang LP; Ma LL; Wang SM
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):520-3. PubMed ID: 18649765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
    Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
    Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta and macrophage migration inhibitory factor (MIF) in dermal fibroblasts mediate UVA-induced matrix metalloproteinase-1 expression.
    Honda A; Abe R; Makino T; Norisugi O; Fujita Y; Watanabe H; Nishihira J; Iwakura Y; Yamagishi S; Shimizu H; Shimizu T
    J Dermatol Sci; 2008 Jan; 49(1):63-72. PubMed ID: 18060744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.